NineSigma, on behalf of Prapela, Inc., seeks organizations interested in collaborating to conduct clinical studies for assessment and regulatory clearance of a non-pharmacological treatment for newborns diagnosed with neonatal abstinence syndrome.
NineSigma invites interested Ohio-based candidates to promptly submit a brief, non-confidential statement of interest.
The purpose of this Notice of Funding Opportunity (NOFO) is to reduce risky alcohol use among women of childbearing age through system-level implementation of alcohol screening and brief intervention (SBI) in health systems providing women’s health services. Risky alcohol use can result in a variety of negative health and social consequences, such as motor vehicle crashes, intimate partner violence, and fetal alcohol spectrum disorders. It is costly, results in over 88,000 deaths annually, and can affect serious medical conditions, such as hypertension, liver disease and certain types of cancer. Health professionals are uniquely positioned to intervene with patients with acute and chronic health conditions caused or exacerbated by risky alcohol use. Alcohol SBI implementation efforts within health systems will focus on development and implementation of: a training and technical assistance plan; alcohol SBI protocols in primary care clinics; system-level approaches that facilitate uptake (e.g., electronic health record integration and performance metrics); an evaluation plan assessing feasibility and impact of system-level implementation; a dissemination plan on promising models and lessons learned; and a sustainability plan. Expected performance outcomes include documenting provider/clinic readiness to conduct alcohol SBI, documenting implementation barriers and proposed solutions, tracking clinic-level data on alcohol SBI, and assessing the use of system-level strategies.
Risky alcohol use can result in a wide range of negative health and social consequences and over time, can result in serious medical conditions, such as hypertension, liver disease, and various types of cancer. Prenatal alcohol exposure can result in fetal alcohol spectrum disorders in the developing baby and is associated with other poor birth outcomes, such as miscarriage, stillbirth, preterm birth, and sudden infant death syndrome.
The U.S. Environmental Protection Agency (EPA) is soliciting applications from eligible organizations to manage a cooperative agreement to help educate the medical community on how to recognize and treat pesticide-related health conditions. The long-term goal of the project is to achieve improved health for communities at risk for overexposure to pesticides through outreach, technical assistance and training to increase knowledge and awareness of environmental and occupational health risks. This is a national environmental and occupational health effort solicited by doctors, clinicians, and state health departments. With this award, EPA seeks to build on the progress of previous project titled "From the Fields to the Exam Room: Integrating the Recognition, Management and Prevention of Pesticide Poisonings into the Primary Care Setting." The publication "Recognition and Management of Pesticide Poisoning" was an earlier product of the initiative. EPA is seeking applications to (1) provide continuing education, training and technical assistance to relevant audiences; (2) update existing, and/or develop new materials and resource tools; (3) conduct outreach to existing and new audiences to use materials and tools; and (4) develop partnerships and a sustainable network of stakeholders. EPA expects to provide an estimated $500,000 annually, depending on the Agency's budget, for a total of up to $2,500,000 for five years (2017 through 2022).
The National Institute of Mental Health (NIMH) with other ICs are issuing this Notice of Intent to Publish a Funding Opportunity Announcement to promote new initiatives that will solicit applications to support research to determine the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), wearable devices] to address secondary health effects of the social, behavioral, and economic changes following the COVID-19 pandemic, particularly among populations who experience health disparities and vulnerable populations.
